News

The EMA (European Medicines Agency) has recommended grant for marketing authorisation in the European Union (EU) for Oxervate (cenegermin) to treat neurotrophic keratitis. Oxervate is a…
Read More...

Sanofi announced that the CHMP (Committee for Medicinal Products for Human Use) of the EMA (European Medicines Agency) recommended the use of Insulin lispro Sanofi (insulin lispro 100…
Read More...

Amgen announced that it has submitted the BLA (Biologics License Application) for Erenumab along with the data from pivotal studies in patients with episodic and chronic migraine to the…
Read More...

Astellas Pharma President and CEO, Yoshihiko Hatanaka announced that they have completed the acquisition of Ogeda SA (Ogeda) and now it has become a wholly owned subsidiary of Astellas…
Read More...

Pharmadax announced that U.S. FDA has approved the generic equivalent of Seroquel XR (quetiapine fumarate) ER tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg, launched by Pharmadex in…
Read More...

Pharmaceutical Product Development (PPD) has expanded its vaccine sciences lab in Richmond, Virginia, to enhance its ability so as to provide industry-leading capabilities to meet…
Read More...

Aduro Biotech announced the expansion of its clinical collaboration with Merck to include an additional Phase 2 clinical trial to evaluate the combination of CRS-207, Aduro’s LADD…
Read More...

Sartorius Stedim Biotech (SSB) and Nova Biomedical has signed a collaboration agreement to integrate their BioProfile FLEX2 into the ambr multi-parallel bioreactor systems for…
Read More...

Kemwell Biopharma announced that it has manufactured and supplied drug substance using its state-of-the-art mammalian cell culture plant in India for clinical trials that will be…
Read More...

Alphaeon announced that it has submitted a BLA (biologic license application) for the Daewoong Botulinum toxin Type A, with the USFDA seeking approval for the treatment of adult…
Read More...

An article published in Experimental Biology and Medicine (Volume 242, Issue 10, May, 2017) identifies a new treatment that may protect the brain from irreversible damage caused by…
Read More...

Maxor National Pharmacy Services announced that Vertex Pharmaceuticals has now included Maxor Specialty in its specialty pharmacy network with immediate effects. Patients may now…
Read More...

Center for Drug Evaluation under China FDA announced that rice-extracted human blood protein is "safe and effective," and its quality can be easily controlled. The Chinese FDA has also…
Read More...

Albireo Pharma announced that USPTO (United States Patent and Trademark Office) has allowed U.S. Patent Application No. 15/276,446, “IBAT inhibitors for the treatment of liver diseases”…
Read More...

Avenue Therapeutics announced that it has received Notice of Allowance from USPTO (U.S. Patent and Trademark Office) for a new patent application (U.S. Application No. 15/163,111),…
Read More...

Greater Than One (GTO) has appointed Kieran Walsh as President of its US operations with immediate effects. Walsh will be responsible for leading the GTO staff and offices in New York…
Read More...

MSD President, Jannie Oosthuizen and Astellas Pharma President and CEO, Yoshihiko Hatanaka together announced that MSD has submitted an application for marketing approval of a…
Read More...

Acasti Pharma announced that it has received an invitation to present the CaPre (omega-3 phospholipid) study results at the National Lipid Association Scientific Sessions in…
Read More...

XOMA Corporation announced it has earned a $10 million milestone payment as one Company asset licensed to one of its pharmaceutical partners advances into clinical development. XOMA…
Read More...

Jubilant Life Sciences Ltd, announced that Jubilant Pharma Limited, a material wholly owned subsidiary of the Company, has received Abbreviated New Drug Application (ANDA)  final …
Read More...